Advertisement
Advertisement
KMTS
Kestra Medical Technologies, Ltd. Common Stock
25.52
USDSponsored
+0.40
+1.58%
Feb 06, 15:59 UTC -5
Closed
After-Market
25.51
-0.01
-0.02%
KMTS Earnings Reports
Positive Surprise Ratio
KMTS beat 1 of 3 last estimates.
33%
Next Report
Date of Next Report
Apr 14, 2026
Estimate for Q3 26 (Revenue/ EPS)
$23.32M
/-$0.60
Implied change from Q2 26 (Revenue/ EPS)
+3.34%
/-6.25%
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Kestra Medical Technologies, Ltd. Common Stock earnings per share and revenue
On Dec 11, 2025, KMTS reported earnings of -0.64 USD per share (EPS) for Q2 26, missing the estimate of -0.60 USD, resulting in a -5.84% surprise. Revenue reached 22.57 million, compared to an expected 21.12 million, with a 6.85% difference. The market reacted with a +5.06% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -0.60 USD, with revenue projected to reach 23.32 million USD, implying an decrease of -6.25% EPS, and increase of 3.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
FAQ
What were Kestra Medical Technologies, Ltd. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Kestra Medical Technologies, Ltd. Common Stock reported EPS of -$0.64, missing estimates by -5.84%, and revenue of $22.57M, 6.85% above expectations.
How did the market react to Kestra Medical Technologies, Ltd. Common Stock's Q2 2026 earnings?
The stock price moved up 5.06%, changed from $24.91 before the earnings release to $26.17 the day after.
When is Kestra Medical Technologies, Ltd. Common Stock expected to report next?
The next earning report is scheduled for Apr 14, 2026.
What are the forecasts for Kestra Medical Technologies, Ltd. Common Stock's next earnings report?
Based on 9
analysts, Kestra Medical Technologies, Ltd. Common Stock is expected to report EPS of -$0.60 and revenue of $23.32M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement